General
Preferred name
URACIL
Synonyms
Uracil (BMS-205603-01 SQ-8493 SQ-7726 SQ-6201 ) ()
Uracil C-13 ()
NSC-3970 ()
BMS-205603-01 ()
SQ-7726 ()
Hybar x ()
Lamivudine impurity e rs ()
Pyrod ()
SQ-6201 ()
Fluorouracil specified compound c ()
Lamivudine impurity e ()
SQ-8493 ()
Uracil-13C,15N2 ()
Uracil-d4 ()
P&D ID
PD001670
CAS
16908-84-2
24897-50-5
138285-60-6
66-22-8
181517-11-3
24897-55-0
Tags
drug candidate
natural product
available
Drug indication
Discovery agent
Antineoplastic (adjunct)
Drug Status
experimental
investigational
Max Phase
Phase 3
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Compound Sets
18
Cayman Chemical Bioactives
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Drug Repurposing Hub
DrugMAP
Enamine BioReference Compounds
Guide to Pharmacology
MedChem Express Bioactive Compound Library
NIH Mechanistic Set
NPC Screening Collection
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
External IDs
56
Properties
(calculated by RDKit )
Molecular Weight
112.03
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
2
Rotatable Bonds
0
Ring Count
1
Aromatic Ring Count
1
cLogP
-0.94
TPSA
65.72
Fraction CSP3
0.0
Chiral centers
0.0
Largest ring
6.0
QED
0.45
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
RNA
DPYD, UCKL1
Endogenous Metabolite
Pathway
Metabolic Enzyme/Protease
Source data